Company · CIK 0001778016 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
NovaBridge Biosciences · NBP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 SForm 4 → | Sep 21, 4:05 pm EDT | Phillip Andrew DennisChief Medical Officer | 8,209 | $0.71 | $5,828 | 173,427 | −4.52% | |
| Sep 17, 2026 MForm 4 → | Sep 21, 4:05 pm EDT | Phillip Andrew DennisChief Medical Officer | 23,695 | — | — | 181,636 | — | |
| Sep 9, 2026 SForm 4 → | Sep 11, 4:30 pm EDT | Sean Wuxiong CaoChief Bus. Development Officer | 107,978 | $0.74 | $79,904 | 266,467 | −28.8% | |
| Sep 3, 2026 MForm 4 → | Sep 8, 5:51 pm EDT | Sean Wuxiong CaoChief Bus. Development Officer | 339,372 | — | — | 374,445 | — | |
| Aug 31, 2026 SForm 4 → | Sep 1, 6:00 pm EDT | Cong Claire XuEVP, Clinical Development | 3,282 | $0.79 | $2,593 | 304,201 | −1.07% | |
| Aug 30, 2026 MForm 4 → | Sep 1, 6:00 pm EDT | Cong Claire XuEVP, Clinical Development | 9,382 | — | — | 307,483 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 MForm 4 → | Sep 21, 4:05 pm EDT | Phillip Andrew DennisChief Medical Officer | 10,302 | — | — | 72,120 | — | |
| Sep 3, 2026 MForm 4 → | Sep 8, 5:51 pm EDT | Sean Wuxiong CaoChief Bus. Development Officer | 147,553 | — | — | 135,960 | — | |
| Aug 30, 2026 MForm 4 → | Sep 1, 6:00 pm EDT | Cong Claire XuEVP, Clinical Development | 4,079 | — | — | 28,558 | — |